IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34 | $46 | $34 | $56 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $35 | $47 | $35 | $57 |
| Revenue | $4 | $4 | $3 | $3 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| % Growth | 6.1% | 25.3% | -6.6% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $0 | $1 |